Improper Access Control in Intel Battery Life Diagnostic Tool
CVE-2022-38786

7.8HIGH

Key Information:

Vendor

Intel
Status
Intel Battery Life Diagnostic Tool Software
Vendor
CVE Published:
14 November 2023

What is CVE-2022-38786?

Improper access control in the Intel Battery Life Diagnostic Tool software prior to version 2.2.1 may allow an authenticated user to escalate privileges through local access. This vulnerability highlights the importance of stringent access control measures to protect sensitive functionalities in software applications. For more information, please refer to the official advisory.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

Intel Battery Life Diagnostic Tool software before version 2.2.1

References

https://www.intel.com/content/www/us/en/security-center/a...

CVSS V3.1

Score:
7.8
Severity:
HIGH
Confidentiality:
High
Integrity:
High
Availability:
High
Attack Vector:
Local
Attack Complexity:
Low
Privileges Required:
Low
User Interaction:
None
Scope:
Unchanged

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.